|
MSN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.827640E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.856900E-03 |
| Normal-vs-Stage2 |
4.493800E-01 |
| Normal-vs-Stage3 |
3.360600E-01 |
| Normal-vs-Stage4 |
5.698600E-01 |
| Stage1-vs-Stage2 |
1.501250E-01 |
| Stage1-vs-Stage3 |
3.937700E-03 |
| Stage1-vs-Stage4 |
3.185800E-01 |
| Stage2-vs-Stage3 |
1.834170E-01 |
| Stage2-vs-Stage4 |
9.566600E-01 |
| Stage3-vs-Stage4 |
2.863400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.306280E-02 |
| Normal-vs-AfricanAmerican |
8.389600E-02 |
| Normal-vs-Asian |
9.135600E-01 |
| Caucasian-vs-AfricanAmerican |
8.377600E-01 |
| Caucasian-vs-Asian |
4.859400E-01 |
| AfricanAmerican-vs-Asian |
5.289400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.622700E-03 |
| Normal-vs-Female |
9.423600E-01 |
| Male-vs-Female |
3.480200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.606300E-02 |
| Normal-vs-Extreme_Weight |
2.723800E-03 |
| Normal-vs-Obese |
7.146600E-01 |
| Normal-vs-Extreme_Obese |
1.257500E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.460400E-01 |
| Normal_Weight-vs-Obese |
1.008020E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.867640E-01 |
| Extreme_Weight-vs-Obese |
4.460300E-03 |
| Extreme_Weight-vs-Extreme_Obese |
2.864400E-01 |
| Obese-vs-Extreme_Obese |
3.022100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.372400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.174000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.152800E-04 |
| Normal-vs-Age(81-100Yrs) |
1.814330E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.491000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.169600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.081700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.563200E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.329810E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.626400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.875200E-03 |
| Normal-VS-Type2 PRCC |
1.164050E-01 |
| Normal-VS-KIRP CIMP |
5.952100E-02 |
| Normal-VS-Unclassified PRCC |
7.598000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.395240E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.157980E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.775300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.354000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.154500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.790200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.159520E-02 |
| Normal-vs-N1 |
2.604600E-01 |
| Normal-vs-N2 |
5.608600E-01 |
| N0-vs-N1 |
2.320600E-03 |
| N0-vs-N2 |
5.142100E-02 |
| N1-vs-N2 |
7.927000E-01 |
|
|
